Berlin, 17 October 2024: The operational key figures for the Hypoport Group’s business models in the first nine months of 2024 improved compared with the prior-year period.

Engineering as the backbone of industrial production and a driver of sustainability: Engineering is crucial for value creation and contributes to achieving the Green Deal goals through sustainable ...

SNP: Significant Increase of Revenue and Earnings in the Third Quarter – Further Raise of Full-Year Guidance 2024 ...

07.10.24 AL Trust Euro Short Term-Fonds: Wertzuwachs von 3,0% im laufenden Jahr - Fondsanalyse (1845 Klicks) ...

08.10 EQS-Adhoc: Nakiki SE: Lett. 08.10 EQS-Adhoc: Nakiki SE: Lett. 08.10 EQS-Adhoc: Shelly Group an. 08.10 EQS-Adhoc: Shelly Group ve. 08.10 Relief Therapeutics Announc. 08.10 VAT Media Release ...

VARTA AG signs agreement with Porsche regarding investment in business unit for large-format lithium-ion cells ...

01.10 EQS-Adhoc: Covestro AG: C. 01.10 EQS-Adhoc: Covestro AG: C. 01.10 EQS-WpÜG: Takeover Offer. 01.10 EQS-WpÜG: Übernahmeange. 01.10 Leclanché SA: Announces E ...

01.10 EQS-Adhoc: KAP AG STR. 01.10 EQS-Adhoc: KAP AG STR. 01.10 EQS-Adhoc: Heidelberg Phar. 01.10 EQS-Adhoc: Heidelberg Phar. 01.10 EQS-Adhoc: DWK Deutsche. 01.10 EQS ...

GENEVA (OCT. 4, 2024) – RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTY) (Relief, or the Company), a biopharmaceutical company committed to delivering innovative treatment options ...

Relief Therapeutics Announces Promising Preliminary Results of RLF-TD011 Clinical Trial in Epidermolysis Bullosa ...

The Board of Management of Deutsche Telekom AG plans to propose to the annual shareholder meeting to increase the dividend for the 2024 financial year to 0.90 euros per dividend-bearing share, up from ...

01.10 EQS-Adhoc: Lang & Schwa. 01.10 HBM Healthcare Investments. 01.10 HBM Healthcare Investments. 01.10 EQS-Adhoc: bioXXmed AG: . 01.10 EQS-Adhoc: Samara Asset . 01. ...